This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
reit: Archive
Digital Realty Acquires Telepoint to Enter Bulgaria Market
by Zacks Equity Research
DLR enters Bulgaria with Telepoint buy, adding two Sofia data centers and boosting its interconnection reach in Southeast Europe.
CUZPositive Net Change DLRPositive Net Change WPCNegative Net Change
cloud-computing finance reit
Top Research Reports for Broadcom, AT&T & Vertex Pharmaceuticals
by Mark Vickery
Broadcom rides AI chip momentum with VMware gains, while AT&T and Vertex navigate growth plans and key headwinds in latest Zacks reports.
TNegative Net Change BKPositive Net Change HSYNegative Net Change VRTXPositive Net Change AVGOPositive Net Change INTGPositive Net Change MRSHNegative Net Change
communications medical reit semiconductor
AvalonBay's Business Update: Trends Match '26 Initial Outlook
by Zacks Equity Research
AVB updates early 2026 metrics as rent and occupancy rise, and targets NOI growth through 2027 amid low regional supply and asset sales.
AVBNegative Net Change EQRNegative Net Change MAANegative Net Change
finance reit
Universal Health Realty Stock Gains Post Q4 Earnings, Revenue Slips
by Zacks Equity Research
UHT posts lower fourth-quarter 2025 earnings and softer revenue, raises dividend and advances new Florida medical office development.
UHTNegative Net Change
earnings finance reit
REIT ETFs in the Spotlight as U.S. Mortgage Rate Sinks Below 6%
by Aparajita Dutta
REIT ETFs, like SCHH, are in focus after the 30-year mortgage rate dipped to 5.98%, boosting real estate valuations and dividend appeal.
AMTNegative Net Change PLDNegative Net Change EQIXNegative Net Change ONegative Net Change LINENegative Net Change VNQNegative Net Change NSANegative Net Change SCHHNegative Net Change USRTNegative Net Change WELLNegative Net Change RIETNo Net Change
etfs reit
Beat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus
by Santanu Roy
Contineum Therapeutics surged 27% after a Zacks Rank upgrade, spotlighting how Zacks' strategies are beating a volatile market.
CVXNegative Net Change ANGOPositive Net Change PGNegative Net Change AMGNPositive Net Change DENegative Net Change PEPNegative Net Change CHDNegative Net Change FCFSNegative Net Change NOBLNegative Net Change SUZNegative Net Change NTSTNegative Net Change CTNMPositive Net Change
biotechnology business-services consumer-staples industrial-products medical medical-devices oil-energy reit
Equinix & CPP Investments to Buy atNorth & Expand Data Center Footprint
by Zacks Equity Research
EQIX teams up with CPP Investments to buy atNorth for $4.2B, boosting its Nordic data center footprint and immediately lifting AFFO per share upon transaction closure.
EQIXNegative Net Change CUZPositive Net Change WPCNegative Net Change
finance reit
Zacks.com featured highlights include Etsy, CBRE and Associated Banc-Corp
by Zacks Equity Research
Etsy, CBRE and Associated Banc-Corp win broker upgrades as AI-driven volatility rattles markets and reshapes investor expectations.
ASBPositive Net Change ETSYPositive Net Change CBREPositive Net Change
reit
Realty Income's $8B Growth Plan: Can Global Push Power Steady Growth?
by Moumita C. Chattopadhyay
O targets $8B in 2026 investments after a $6.3B 2025 haul, expanding globally and tapping new capital to sustain growth momentum.
SPGPositive Net Change FRTNegative Net Change ONegative Net Change
reit retail
Realty Income Stock: A Buy, Hold or Sell Opportunity Post Q4 Earnings?
by Moumita C. Chattopadhyay
O ends 2025 with steady AFFO, 98.9% occupancy and an $8B 2026 investment plan, yet rate risks keep the buy-or-hold debate alive.
ONegative Net Change ADCNegative Net Change EPRTNegative Net Change
finance reit retail